Biosimilars

The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

FDA approved. | Image Credit: Olivier Le Moal - stock.adobe.com
FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra

January 31st 2025

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.

Kirollos Hanna, PharmD
Embracing EOM, Enhancing Collaboration and Cost Management: Dr Kirollos Hanna

January 29th 2025

France | Image Credit: lazyllama - stock.adobe.com
Ustekinumab Biosimilar Launches in France, Shifts the Autoimmune Disease Market

January 27th 2025

Market share. | Image Credit:  sirichai - stock.adobe.com
Biosimilar Market Share: Growth and Price Trends in Q1 2025

January 23rd 2025

Patent litigation. | Image Credit: LALAKA - stock.adobe.com
Patent Litigation Impacts on US Biosimilar Market Entry

January 22nd 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo